Product Description
Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free Zithromax cases. Here at Leading Justice, we can custom-tailor your firm’s Zithromax advertising needs and help you sign up cases via internal cash buys. Our clients simply pay an agency fee to cover the cost of Zithromax advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, which means any data we generate that isn’t eligible for the target campaign is reviewed to see if it qualifies for another type of claim. By using advanced approaches to target contacts specifically associated with Zithromax and birth defects like epilepsy and cerebral palsy, Leading Justice will increase your firm’s Zithromax case load. If you are interested in helping victims of alleged Zithromax birth defects, our vast consumer reach and direct advertising strategies give you the competitive edge and confidence to allocate your full budget, knowing that your money is being spent in the best way possible.
Each law firm we work with at Leading Justice plays an integral role in how we classify leads as qualified or not. Our extensive experience working with plaintiff law firms allows us to recognize a great case when we see one, but we will also customize our Zithromax (Z-Pak) case intake specifications to the exact criteria you are seeking. So, if your firm has specific Zithromax qualifying case criteria you would like us to use, we can train our intake specialists to apply the criteria to each phone call and email they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of Zithromax data with zero chance of fraud.
Zithromax Birth Defect Litigation
Zithromax (azithromycin) is manufactured by Pfizer and is one of the most widely-used antibiotic drugs in the world, commonly prescribed to treat infections caused by bacteria, including respiratory infections, skin infections and ear infections. Zithromax (Z-Pak) is also sometimes prescribed to treat urinary tract infections and other infections in women who are pregnant, a practice that researchers say could lead to serious birth defects in babies exposed to the medication in pregnancy. According to one recent study, published in the medical journal PLOS One in March 2015, women who took Zithromax during pregnancy were close to 80% more likely to give birth to a baby with epilepsy or cerebral palsy birth defects. In addition to an increased risk of birth defects in babies exposed to Zithromax in utero, the antibiotic drug has also been tied to serious side effects in patients, including liver injury, infantile hypertrophic pyloric stenosis (IHPS), and heart rhythm problems possibly leading to death.
Despite the potential risk of birth defects tied to Zithromax use in pregnancy, the FDA has classified the antibiotic medication as a pregnancy Category B drug, which means it is not expected to cause harm to unborn babies. This means that even pregnant women responsible enough to discuss with their doctors the risk of side effects from Zithromax before taking the drug, may be unaware of the potential for the antibiotic to interfere with the normal development of their unborn baby. Even more alarming, the researchers involved in the PLOS One Zithromax study, which examined data from nearly 200,000 pregnant women, found that between 19% and 44% of the women were prescribed antibiotic drugs like Zithromax during pregnancy. As more information comes to light about the alleged risk of birth defects from Zithromax, consumers across the country who believe they have been harmed by the antibiotic drug are expected to pursue legal action against Pfizer in the coming years.
